IDEXX Laboratories, Inc.
IDXX
$652.23
-$0.04-0.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.14% | 12.27% | -7.17% | 14.53% | -13.70% |
| Total Depreciation and Amortization | 5.02% | 1.06% | -1.25% | 6.03% | 7.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.45% | 4.80% | 99.61% | 817.33% | -110.06% |
| Change in Net Operating Assets | -170.00% | -594.76% | 84.77% | -501.71% | 117.54% |
| Cash from Operations | -21.94% | -9.18% | 19.06% | -11.37% | 25.04% |
| Capital Expenditure | -13.57% | -2.64% | -4.15% | 15.66% | -10.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -100.00% | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.94% | 103.93% | -2,651.33% | 4.27% | 20.97% |
| Cash from Investing | -13.57% | 25.68% | -45.58% | 16.83% | 69.23% |
| Total Debt Issued | 273.38% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 140.93% | -45.73% | 165.31% | -6.83% | -74.32% |
| Repurchase of Common Stock | 16.69% | -65.43% | -11.34% | -2.49% | -30.70% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 49.86% | -41.90% | 20.00% | -38.40% | -45.92% |
| Foreign Exchange rate Adjustments | 707.65% | 76.18% | -283.85% | 626.14% | 75.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.50% | -510.19% | 78.09% | -2,336.08% | 107.36% |